South Korea allows use of Gilead's remdesivir to treat Covid-19 patients

The South Korean government's fast-track import approval on Wednesday came after health authorities concluded that the drug could possibly help patients recover faster

South Korea's Food and Drug Safety Ministry has allowed the use of Gilead Sciences' antiviral drug remdesivir in treatment of Covid-19 patients.

The ministry's fast-track import approval on Wednesday came after health authorities concluded that the drug could possibly help patients recover faster.

Officials plan to soon hold discussions with Gilead to arrange the drug shipments.

The US food and drug regulatory body has allowed emergency use of an investigational anti-viral vaccine to treat Covid-19 patients after some researches, including one led by